Parker SM, Smith JA, Birring SS, Chamberlain-Mitchell S, Gruffydd-Jones K, Haines J, Hennessey S, McGarvey LP, Marsden P, Martin MJ, Morice A, O’Hara J, Thomas M. British Thoracic Society Clinical Statement on chronic cough in adults. Thorax. 2023 Dec 6;78(Suppl 6):s3-s19
Zayseva O.A et al. Analysis Of Pharmacological Properties Of Antitussive Drugs. Journal Of Medicine And Pharmacy.2024; 7(6):11-19. Available at https://doi.org/10.5281/zenodo.11641163. Accessed on March 6, 2025:
Germouty J, Weibel MA. Comparaison clinique du citrate de butamirate avec un antitussif à base de codéine [Clinical comparison of butamirate citrate with a codeine-based antitussive agent]. Rev Med Suisse Romande. 1990 Nov;110(11):983-6
Morice A, Kardos P. Comprehensive evidence-based review on European antitussives. BMJ Open Respir Res. 2016 Aug 5;3(1):e000137
Zayseva O.A et al. Analysis Of Pharmacological Properties Of Antitussive Drugs. Journal Of Medicine And Pharmacy.2024; 7(6):11-19. Available at https://doi.org/10.5281/zenodo.11641163. Accessed on March 6, 2025:
Zayseva O.A et al. Analysis Of Pharmacological Properties Of Antitussive Drugs. Journal Of Medicine And Pharmacy.2024; 7(6):11-19. Available at https://doi.org/10.5281/zenodo.11641163. Accessed on March 6, 2025:
Germouty J, Weibel MA. Comparaison clinique du citrate de butamirate avec un antitussif à base de codéine [Clinical comparison of butamirate citrate with a codeine-based antitussive agent]. Rev Med Suisse Romande. 1990 Nov;110(11):983-6
Zayseva O.A et al. Analysis Of Pharmacological Properties Of Antitussive Drugs. Journal Of Medicine And Pharmacy.2024; 7(6):11-19. Available at https://doi.org/10.5281/zenodo.11641163. Accessed on March 6, 2025:
Germouty J, Weibel MA. Comparaison clinique du citrate de butamirate avec un antitussif à base de codéine [Clinical comparison of butamirate citrate with a codeine-based antitussive agent]. Rev Med Suisse Romande. 1990 Nov;110(11):983-6
Charpin J, Weibel MA. Comparative evaluation of the antitussive activity of butamirate citrate linctus versus clobutinol syrup. Respiration. 1990;57(4):275-9
Germouty J, Weibel MA. Comparaison clinique du citrate de butamirate avec un antitussif à base de codéine [Clinical comparison of butamirate citrate with a codeine-based antitussive agent]. Rev Med Suisse Romande. 1990 Nov;110(11):983-6
AMBROXOL (DURO-TUSS® AX) 30 mg/ 5 mL Syrup PRODUCT INSERT
Raja MG et al., IJPSR, 2012; Vol. 3(8): 2658-2663:
Raja MG et al., IJPSR, 2012; Vol. 3(8): 2658-2663:
Germouty J, Jirou-Najou JL. Clinical efficacy of ambroxol in the treatment of bronchial stasis. Clinical trial in 120 patients at two different doses. Respiration. 1987;51 Suppl 1:37-41
Kantar A, Klimek L, et al. Multidiscip Respir Med. 2020 Mar 3;15(1):511
AMBROXOL (DURO-TUSS® AX) 30 mg/ 5 mL Syrup PRODUCT INSERT
Scaglione F, Petrini O. Clin Med Insights Ear Nose Throat. 2019 Jan 9;12:1179550618821930:
Kantar A, Klimek L, et al. Multidiscip Respir Med. 2020 Mar 3;15(1):511:
Malerba M, Ragnoli B. Expert Opin Drug Metab Toxicol. 2008 Aug;4(8):1119-29:
Germouty J, Jirou-Najou JL. Clinical efficacy of ambroxol in the treatment of bronchial stasis. Clinical trial in 120 patients at two different doses. Respiration. 1987;51 Suppl 1:37-41
Ollier, C et al. Pulm Ther (2020) 6:119–130:
Beeh, KM at al. Eur J Med Res (2008) 13: 557-562:
Kantar A, Klimek L, et al. Multidiscip Respir Med. 2020 Mar 3;15(1):511:
Germouty J, Jirou-Najou JL. Clinical efficacy of ambroxol in the treatment of bronchial stasis. Clinical trial in 120 patients at two different doses. Respiration. 1987;51 Suppl 1:37-41
Malerba M, Ragnoli B. Expert Opin Drug Metab Toxicol. 2008 Aug;4(8):1119-29:
